Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Amgen
Biotech

Amgen posts ph. 3 Sjögren’s data ahead of Novartis showdown

Amgen shared data from a phase 3 Sjögren’s disease trial that dazzled analysts, digging into the details that could shape its showdown with Novartis.
Nick Paul Taylor Nov 11, 2026 8:00am
a lot of scissors

Capricor, NextCure shed light on recent layoffs

Nov 11, 2026 4:48am
Podcast
Top Line Podcast - ZS

Use Kidney Genetics to Strengthen Clinical Trial Design

Brought to you by Natera
sickle cell disease

Beam’s sickle cell results signal Casgevy, Lyfgenia showdown

Nov 10, 2026 3:19pm
Advanced Analytics Help Reduce Control Animal Use While Preserving Scientific Rigor

How Virtual Control Groups Are Shaping Safety Studies

Brought to you by Charles River Laboratories
In Laboratory Over the Shoulder View of Scientist in Protective Clothes Doing Research on a Personal Computer

PepGen’s stock doubles as midphase DM1 data wow analysts

Nov 10, 2026 10:21am